Institut Pasteur de Tunis

2 in Phase 3

Quick facts

Phase 3 pipeline

CoronaVac/BNT162b2 · Immunology / Infectious Disease
This is a combination COVID-19 vaccine regimen using CoronaVac (inactivated virus vaccine) followed by BNT162b2 (mRNA vaccine) to stimulate immune responses against SARS-CoV-2.
CoronaVac/CoronaVac · Immunology / Infectious Disease
CoronaVac is an inactivated SARS-CoV-2 vaccine that stimulates the immune system to produce antibodies and cellular immunity against the virus.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: